- Home
- TFSL vs PCVX Comparison
TFSL vs PCVX Comparison
Compare TFSL & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFSL
- PCVX
- Stock Information
- Founded
- TFSL 1938
- PCVX 2013
- Country
- TFSL United States
- PCVX United States
- Employees
- TFSL N/A
- PCVX N/A
- Industry
- TFSL Savings Institutions
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- TFSL Finance
- PCVX Health Care
- Exchange
- TFSL Nasdaq
- PCVX Nasdaq
- Market Cap
- TFSL 3.9B
- PCVX 4.0B
- IPO Year
- TFSL 2007
- PCVX 2020
- Fundamental
- Price
- TFSL $13.24
- PCVX $42.37
- Analyst Decision
- TFSL Hold
- PCVX Strong Buy
- Analyst Count
- TFSL 1
- PCVX 8
- Target Price
- TFSL $15.00
- PCVX $114.17
- AVG Volume (30 Days)
- TFSL 426.3K
- PCVX 2.0M
- Earning Date
- TFSL 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- TFSL 8.40%
- PCVX N/A
- EPS Growth
- TFSL 3.58
- PCVX N/A
- EPS
- TFSL 0.29
- PCVX N/A
- Revenue
- TFSL $308,625,000.00
- PCVX N/A
- Revenue This Year
- TFSL $7.25
- PCVX N/A
- Revenue Next Year
- TFSL $7.66
- PCVX N/A
- P/E Ratio
- TFSL $46.38
- PCVX N/A
- Revenue Growth
- TFSL 1.03
- PCVX N/A
- 52 Week Low
- TFSL $11.29
- PCVX $27.66
- 52 Week High
- TFSL $15.00
- PCVX $118.62
- Technical
- Relative Strength Index (RSI)
- TFSL 47.57
- PCVX 72.01
- Support Level
- TFSL $13.01
- PCVX $40.35
- Resistance Level
- TFSL $13.82
- PCVX $42.86
- Average True Range (ATR)
- TFSL 0.22
- PCVX 1.94
- MACD
- TFSL 0.01
- PCVX 0.86
- Stochastic Oscillator
- TFSL 32.10
- PCVX 90.78
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.